Fibromyxoid Tumor
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas (NCT03600649) | Salarius Pharmaceuticals, LLC | 2018-06-04 |
| Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (NCT02834013) | National Cancer Institute (NCI) | 2017-01-30 |
Track Fibromyxoid Tumor automatically
Every clearance here is in the API, with alerts when new ones post.